Donahoe PK - Search Results

1

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors.

Kim JH, MacLaughlin DT, Donahoe PK. Kim JH, et al. Among authors: donahoe pk. Obstet Gynecol Sci. 2014 Sep;57(5):343-57. doi: 10.5468/ogs.2014.57.5.343. Epub 2014 Sep 17. Obstet Gynecol Sci. 2014. PMID: 25264524 Free PMC article. Review.

2

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT. Ragin RC, et al. Among authors: donahoe pk. Protein Expr Purif. 1992 Jun;3(3):236-45. doi: 10.1016/1046-5928(92)90020-w. Protein Expr Purif. 1992. PMID: 1392620

3

Identification of müllerian inhibiting substance specific binding in human cell lines.

MacLaughlin DT, Levin RK, Catlin EA, Taylor LA, Preffer FI, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Horm Metab Res. 1992 Dec;24(12):570-5. doi: 10.1055/s-2007-1003392. Horm Metab Res. 1992. PMID: 1478615

4

Mullerian inhibiting substance binding and uptake.

Catlin EA, Ezzell RM, Donahoe PK, Manganaro TF, Ebb RG, MacLaughlin DT. Catlin EA, et al. Among authors: donahoe pk. Dev Dyn. 1992 Apr;193(4):295-9. doi: 10.1002/aja.1001930402. Dev Dyn. 1992. PMID: 1511169 Free article.

5

The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.

Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, Richards CJ. Kim JH, et al. Among authors: donahoe pk. J Clin Endocrinol Metab. 1992 Sep;75(3):911-7. doi: 10.1210/jcem.75.3.1517385. J Clin Endocrinol Metab. 1992. PMID: 1517385

6

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Endocrinology. 1992 Jul;131(1):291-6. doi: 10.1210/endo.131.1.1612008. Endocrinology. 1992. PMID: 1612008

7

Müllerian inhibiting substance in reproduction and cancer.

Donahoe PK. Donahoe PK. Mol Reprod Dev. 1992 Jun;32(2):168-72. doi: 10.1002/mrd.1080320213. Mol Reprod Dev. 1992. PMID: 1637555 Review.

8

Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.

Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF Jr. Gustafson ML, et al. Among authors: donahoe pk. N Engl J Med. 1992 Feb 13;326(7):466-71. doi: 10.1056/NEJM199202133260707. N Engl J Med. 1992. PMID: 1732773 Free article. No abstract available.

9

The critical period for mullerian duct regression in the dog embryo.

Meyers-Wallen VN, Manganaro TF, Kuroda T, Concannon PW, MacLaughlin DT, Donahoe PK. Meyers-Wallen VN, et al. Among authors: donahoe pk. Biol Reprod. 1991 Oct;45(4):626-33. doi: 10.1095/biolreprod45.4.626. Biol Reprod. 1991. PMID: 1751638

10

Bioassay, purification, cloning, and expression of müllerian inhibiting substance.

MacLaughlin DT, Epstein J, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Methods Enzymol. 1991;198:358-69. doi: 10.1016/0076-6879(91)98037-7. Methods Enzymol. 1991. PMID: 1857229 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page